Early phase study to assess efficacy and safety of AZD9567 versus prednisolone in patients with rheumatoid arthritis

Trial Identifier:	D6470C00003
Sponsor:	AstraZeneca
NCTID::	NCT03368235
Start Date:	January 2018
Primary Completion Date:	November 2019
Study Completion Date:	November 2019
Condition:	Rheumatoid Arthritis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	Swedish Translation
	Dutch Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Netherlands	Enschede, Netherlands, 7512 KZ
Netherlands	Maastricht, Netherlands, 6229 HX
Netherlands	UTRECHT, Netherlands, 3584 CX
Sweden	Göteborg, Sweden, 413 45
Sweden	Lund, Sweden, 221 85

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company